Related Experiment Video
Updated: Aug 15, 2026

Full-Field Optical Coherence Microscopy for Histology-Like Analysis of Stromal Features in Corneal Grafts
Published on: October 21, 2022
Aphakic bullous keratopathy treated with prosthokeratoplasty. An analysis of 34 consecutive cases
Insights
The Cardona keratoprosthesis effectively treated advanced aphakic bullous keratopathy in 82% of eyes. This artificial cornea implant showed significant visual improvement, despite a 9% extrusion rate.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Surgical Innovation
Background:
- Aphakic bullous keratopathy presents a significant challenge in corneal disease management.
- Advanced cases often require complex surgical interventions beyond standard penetrating keratoplasty.
- The Cardona keratoprosthesis offers an alternative prosthetic option for severe corneal opacity.
Purpose of the Study:
- To evaluate the efficacy and safety of the Cardona keratoprosthesis as a primary treatment for advanced aphakic bullous keratopathy.
- To compare the outcomes and complications of the Cardona keratoprosthesis with those of traditional penetrating keratoplasty.
Main Methods:
- A cohort of 34 eyes with advanced aphakic bullous keratopathy underwent primary implantation of the Cardona keratoprosthesis.
- Patient outcomes were monitored over follow-up periods ranging from 6 to 72 months.
- Complications such as extrusion and infection were recorded and analyzed.
Main Results:
- A notable improvement in visual function was observed in 28 out of 34 eyes (82%).
- Complications included three device extrusions (9%), with two cases linked to infection.
- Two eyes (6%) experienced worsened conditions due to vitreous hemorrhage or potential infection.
Conclusions:
- The Cardona keratoprosthesis demonstrates significant potential for improving vision in eyes with advanced aphakic bullous keratopathy.
- While effective, potential complications like extrusion and infection necessitate careful patient selection and monitoring.
- This prosthetic approach offers a viable alternative to penetrating keratoplasty for specific patient profiles.
Abstract:
Thirty-four eyes with advanced aphakic bullous keratopathy were treated with the Cardona keratoprosthesis as a primary procedure. There were three extrusions (9%), two of which were associated with infections; two other conditions were worsened (6%) as a result of a late permanent vitreous hemorrhage or possibly an infection. Twenty-eight eyes (82%) showed a notable improvement during follow-up periods that ranged from 6 to 72 months. The advantages and limitations of this technique are compared to those of penetrating keratoplasty.

